MedTrace Logo

Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding

NCT02755324 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2020-11-18

No results posted yet for this study

Summary

Groups of 3 or 7 volunteers will be exposed to a predetermined number of male Schistosoma mansoni cercariae until 10 volunteers are found infected.

Conditions

  • Schistosomiasis
  • Schistosoma Mansoni

Interventions

BIOLOGICAL

male Schistosoma mansoni cercariae

Viable male Schistosoma mansoni cercariae of the Puerto Rican strain

Sponsors & Collaborators

  • Leiden University

    lead OTHER

Principal Investigators

  • Meta Roestenberg · LUMC

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-27
Primary Completion
2018-07-19
Completion
2019-01-21

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02755324 on ClinicalTrials.gov